Overview
Nasal glial heterotopia, also commonly known as nasal glioma, is a rare congenital developmental malformation consisting of ectopic brain tissue (glial tissue) located in or around the nose. Despite the term 'glioma,' this condition is not a true neoplasm but rather a developmental anomaly resulting from sequestration of glial tissue outside the cranial cavity during embryonic development. It is thought to represent a form of encephalocele that has lost its intracranial connection, though in some cases a fibrous stalk connecting to the dura mater may persist. Nasal glial heterotopia typically presents at birth or in early infancy as a firm, non-compressible mass located either externally on the nasal bridge (extranasal, approximately 60% of cases), within the nasal cavity (intranasal, approximately 30%), or in a combined location (approximately 10%). External lesions appear as smooth, firm, skin-covered masses near the root of the nose, sometimes with a bluish discoloration. Intranasal lesions may cause nasal obstruction, difficulty breathing (especially in neonates who are obligate nasal breathers), and feeding difficulties. The mass does not transilluminate and does not increase in size with crying or straining (Furstenberg test negative), which helps distinguish it from an encephalocele. Rarely, the condition may be associated with other craniofacial anomalies. Diagnosis is established through clinical examination, imaging studies (CT and MRI are essential to evaluate any intracranial connection and to differentiate from encephalocele), and histopathological confirmation showing mature glial tissue with astrocytes embedded in a fibrous connective tissue matrix. Treatment is primarily surgical excision, which is both diagnostic and curative. Complete surgical removal is important to prevent recurrence, which occurs in approximately 10% of incompletely excised cases. Prognosis after complete excision is excellent, with no risk of malignant transformation. Preoperative imaging is critical to rule out intracranial communication before any surgical intervention is attempted.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Nasal glial heterotopia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Nasal glial heterotopia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Nasal glial heterotopia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Nasal glial heterotopia.
Community
No community posts yet. Be the first to share your experience with Nasal glial heterotopia.
Start the conversation →Latest news about Nasal glial heterotopia
No recent news articles for Nasal glial heterotopia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Nasal glial heterotopia
What is Nasal glial heterotopia?
Nasal glial heterotopia, also commonly known as nasal glioma, is a rare congenital developmental malformation consisting of ectopic brain tissue (glial tissue) located in or around the nose. Despite the term 'glioma,' this condition is not a true neoplasm but rather a developmental anomaly resulting from sequestration of glial tissue outside the cranial cavity during embryonic development. It is thought to represent a form of encephalocele that has lost its intracranial connection, though in some cases a fibrous stalk connecting to the dura mater may persist. Nasal glial heterotopia typically
How is Nasal glial heterotopia inherited?
Nasal glial heterotopia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Nasal glial heterotopia typically begin?
Typical onset of Nasal glial heterotopia is neonatal. Age of onset can vary across affected individuals.